About BNJ Biopharma
BNJ Biopharma is a Healthcare company based in South Korea founded in 2021 by Jae-June Dong, and was acquired by The Invention Lab in December 2023. AI-based anti-cancer drugs are developed using tumor diversity data. Its chief executive, as recorded, is Jae-June Dong. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development.
Company details
BNJ Biopharma was founded in 2021 in South Korea as an AI-based drug development company. Focus is placed on designing anti-cancer drugs through analysis of tumor diversity data. Seed funding was obtained from INNOCUVE, with additional investment recently secured from The Invention Lab. Operations center on biotechnology and pharmaceutical innovation in the region.
- Headquarters South Korea
- Founders Jae-June Dong
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bnjbio.com
- Acquired by The Invention Lab (Dec 2023)
- Investors
- Acquired byThe Invention Lab
(Dec 2023)
Investors in BNJ Biopharma
BNJ Biopharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Invention Lab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
The Invention Lab is recognized as a startup accelerator and seed investment firm. | theilab.kr | Seoul, South Korea |
Investor details for BNJ Biopharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BNJ Biopharma
1 people are tracked at BNJ Biopharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jae-June Dong | Founder & CEO | Leadership |
Complete people profiles for BNJ Biopharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BNJ Biopharma
2 dated milestones of BNJ Biopharma across 2 years, from founding to its latest funding, stage changes and deals.
- Founded BNJ Biopharma is founded.
- Exit Acquired by The Invention Lab.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BNJ Biopharma
BNJ Biopharma was founded in 2021.
BNJ Biopharma is headquartered in South Korea.
Jae-June Dong is the CEO of BNJ Biopharma, as recorded in our data. They have also founded this company.
BNJ Biopharma was founded in 2021 in South Korea as an AI-based drug development company. Focus is placed on designing anti-cancer drugs through analysis of tumor diversity data. Seed funding was obtained from INNOCUVE, with additional investment recently secured from The Invention Lab. Operations center on biotechnology and pharmaceutical innovation in the region.
BNJ Biopharma has 1 investor. Key investors include The Invention Lab.
Yes. BNJ Biopharma was acquired by The Invention Lab in December 2023.